Table of Content


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Global Market Size
Chapter 3 Market Overview
Market Dynamics
Drivers
Market Restraints
Market Opportunities
Chapter 4 Regulatory and Patent Landscape
Regulatory Landscape
U.S.
Europe
Asia-Pacific
Patent Reviews
Chapter 5 Market Trends
Product Pipeline
Future Potential Treatments
Strategies and Developments
Chapter 6 Impact of COVID-19 on Market
Overview
COVID-19 Crisis
Short-Term Impact on Pharmaceutical Industry
Long-Term Impact
Impact on Supply Chain
Impact of COVID-19 on the Market for Minoxidil
Current Outlook
Chapter 7 Market Breakdown by Type
2% Minoxidil
5% Minoxidil
10% Minoxidil
Chapter 8 Market Breakdown by Form
Topical
Oral Minoxidil
Chapter 9 Market Breakdown by Application
Alopecia
Other Chronic Diseases
Chapter 10 Market Breakdown by Region
Overview
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
India
China
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Chapter 11 Company Profiles
APOTEX INC.
CIPLA
DR. REDDY’S LABORATORIES LTD.
JOHNSON & JOHNSON
MYLAN (VIATRIS)
NOVARTIS AG
PERRIGO COMPANY PLC
PFIZER INC.
TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Chapter 12 Appendix: Acronyms Used in this Report



List of Figures



Summary Figure : Global Market for Minoxidil, by Type, 2019-2025
Figure 1 : Trends in Global Elderly (60+ Years) Population Growth, 1990-2100
Figure 2 : Impact of COVID-19 on Pharmaceutical Industry
Figure 3 : Global Market for 2% Minoxidil Solution, 2019-2025
Figure 4 : Global Market for 5% Minoxidil Solution, 2019-2025
Figure 5 : Global Market for 10% Minoxidil Solution, 2019-2025
Figure 6 : Global Market for Topical Minoxidil, 2019-2025
Figure 7 : Global Market for Oral Minoxidil, 2019-2025
Figure 8 : Global Market for Minoxidil in the Treatment of Alopecia, 2019-2025
Figure 9 : Global Market for Minoxidil in the Treatment of Other Chronic Diseases, 2019-2025
Figure 10 : Global Market for Minoxidil, by Region, 2019-2025
Figure 11 : Global Market Shares for Minoxidil, by Region, 2019
Figure 12 : North American Market for Minoxidil, 2019-2025
Figure 13 : European Market for Minoxidil, 2019-2025
Figure 14 : Asia-Pacific Market for Minoxidil, 2019-2025
Figure 15 : Rest of World Market for Minoxidil, 2019-2025

List of Tables



Summary Table : Global Market for Minoxidil, by Region, Through 2025
Table 1 : Global Elderly (60+) Population Growth, 1980-2020
Table 2 : Drug Alternatives for Alopecia
Table 3 : Natural Alternatives for Alopecia
Table 4 : Patents Issued for Minoxidil
Table 5 : U.S. Patents Issued for Hair Loss Treatment
Table 6 : Minoxidil Pipeline
Table 7 : Potential Treatment Options for Types of Alopecia
Table 8 : Breakthrough Therapy Designation, 2018-2020
Table 9 : Global Market for 2% Minoxidil Solution, by Region, Through 2025
Table 10 : Global Market for 5% Minoxidil Solution, by Region, Through 2025
Table 11 : Global Market for 10% Minoxidil Solution, by Region, Through 2025
Table 12 : Global Market for Topical Minoxidil, by Region, Through 2025
Table 13 : Global Market for Oral Minoxidil, by Region, Through 2025
Table 14 : Classification of Alopecia
Table 15 : Global Market for Minoxidil in the Treatment of Alopecia, by Region, Through 2025
Table 16 : Global Market for Minoxidil in the Treatment of Other Chronic Diseases, by Region, Through 2025
Table 17 : North American Market for Minoxidil, by Country, Through 2025
Table 18 : European Market for Minoxidil, by Country, Through 2025
Table 19 : Asia-Pacific Market for Minoxidil, by Country, Through 2025
Table 20 : Apotex: Minoxidil Product Portfolio
Table 21 : Cipla: Minoxidil Product Portfolio
Table 22 : Dr. Reddy’s Laboratories: Minoxidil Product Portfolio
Table 23 : Dr. Reddy’s Laboratories: Key Developments, 2018
Table 24 : Johnson & Johnson: Minoxidil Product Portfolio
Table 25 : Johnson & Johnson: Key Developments, 2018
Table 26 : Mylan: Minoxidil Product Portfolio.
Table 27 : Sandoz: Minoxidil Product Portfolio
Table 28 : Perrigo Company Plc: Minoxidil Product Portfolio
Table 29 : Perrigo Company Plc: Key Developments, 2018
Table 30 : Pfizer: Minoxidil Product Portfolio
Table 31 : Taisho Pharmaceutical: Minoxidil Products
Table 32 : Teva Pharmaceutical: Minoxidil Products
Table 33 : Teva Pharmaceutical: Key Developments
Table 34 : Acronyms Used in This Report